Optimal asparaginase therapy.
Holcenberg
John
J
Department of Pediatrics, Division of Hematology-Oncology, University of Washington School of Medicine, Seattle, Washington, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001215:Asparaginase / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D001215:Asparaginase